532531 Stock Overview
Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
Strides Pharma Science Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹882.15 |
| 52 Week High | ₹903.80 |
| 52 Week Low | ₹330.35 |
| Beta | 0.78 |
| 1 Month Change | 13.75% |
| 3 Month Change | 28.64% |
| 1 Year Change | 159.07% |
| 3 Year Change | -0.068% |
| 5 Year Change | 83.72% |
| Change since IPO | 570.84% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532531 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 5.3% | -0.1% | 1.8% |
| 1Y | 159.1% | 55.9% | 46.4% |
Return vs Industry: 532531 exceeded the Indian Pharmaceuticals industry which returned 55.3% over the past year.
Return vs Market: 532531 exceeded the Indian Market which returned 46.1% over the past year.
Price Volatility
| 532531 volatility | |
|---|---|
| 532531 Average Weekly Movement | 5.1% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 532531's share price has been volatile over the past 3 months.
Volatility Over Time: 532531's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 2,850 | Arun Pillai | www.strides.com |
Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, powders, solids, ointments, and creams.
Strides Pharma Science Limited Fundamentals Summary
| 532531 fundamental statistics | |
|---|---|
| Market cap | ₹81.03b |
| Earnings (TTM) | -₹1.52b |
| Revenue (TTM) | ₹39.53b |
2.0x
P/S Ratio-53.1x
P/E RatioIs 532531 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532531 income statement (TTM) | |
|---|---|
| Revenue | ₹39.53b |
| Cost of Revenue | ₹17.56b |
| Gross Profit | ₹21.97b |
| Other Expenses | ₹23.50b |
| Earnings | -₹1.52b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -16.59 |
| Gross Margin | 55.58% |
| Net Profit Margin | -3.86% |
| Debt/Equity Ratio | 140.2% |
How did 532531 perform over the long term?
See historical performance and comparison